Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily prescribed for the management of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities
Animal studies have suggested that metformin enhances the weight loss efficacy of GLP-1 RAs by stimulating GLP-1 receptor expression and augmenting insulin-mediated signaling pathways
The Semaglutide medication is administered via patient injection in the arm, stomach, or upper leg
Tirzepatides dual-action mechanism may make it more effective for some patients, while Semaglutide remains a trusted, proven option with a strong track record
Its not a magic cure, and it wont do the work for you
Zaleca si rwnie regularne monitorowanie reakcji organizmu na semaglutyd oraz natychmiastowe zgaszanie wszelkich niepodanych dziaa lekarzowi